Business

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

CHICAGO, IL / ACCESS Newswire / February 6, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated

articleCosmos Health Inc.February 6, 20254/company/cosmos-health-inc/news/cosmos-health-receives-dollar578460-initial-purchase-order-from-al-rabwa-international-for-sky-premium-life-food-supplements-in-qatar
Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

About this update from Cosmos Health Inc.

[{"type":"text","content":"CHICAGO, IL / ACCESS Newswire / February 6, 2025 / Cosmos Health Inc. (\"Cosmos Health\" or the \"Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has received an initial purchase order of $578,460 from Al Rabwa International Services and Trading (\"Al Rabwa\") for its Sky Premium Life® food supplement products in Qatar.The initial purchase order covers 35 of the Company's 79 SKUs. Al Rabwa has been granted exclusivity, and the Company looks forward to strengthening this partnership through additional future orders.Established in 2013, Al Rabwa has successfully evolved into one of the leading distribution companies in Qatar, catering to retail, food service, and wholesale sectors. Al Rabwa's extensive product portfolio is backed by a network of reputable global suppliers and producers, complemented by a professional, world-class approach to sales, marketing, and customer service - giving the company a leading edge in Qatar's distribution space.Greg Siokas, CEO of Cosmos Health, stated: \"We are delighted to announce our first order from Al Rabwa, allowing us to capitalize on Qatar's rapidly expanding market. This is another important partnership for Cosmos and a testament to the high quality of our products and the strong global demand they continue to attract.\"About Cosmos Health Inc.Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, t...

More updates from Cosmos Health Inc.